Rafael Holdings Inc.

05/24/2022 | Press release | Distributed by Public on 05/24/2022 10:29

European Medicines Agency Grants Orphan Drug Designation to Cornerstone Pharmaceuticals’ CPI-613® (Devimistat) for Treatment of Patients with Advanced Unresectable Biliary[...]